Metropolitan Life Insurance CO Fate Therapeutics Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.54 - $8.35 $8,658 - $20,424	2,446 Added 114.09%	4,590 $33,000
Q4 2023 Feb 14, 2024	SELL	$1.65 - $3.94 $3,928 - $9,381	-2,381 Reduced 52.62%	2,144 $8,000
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $1,895 - $4,970	-447 Reduced 8.99%	4,525 $25,000
Q4 2022 Jun 14, 2023	BUY	$9.86 - $23.83 $4,407 - $10,652	447 Added 9.88%	4,972 $50.2 Million
Q3 2022 Jun 14, 2023	BUY	$21.04 - $36.06 $9,404 - $16,118	447 Added 9.88%	4,972 $111 Million
Q2 2022 Jun 20, 2023	BUY	$17.78 - $42.39 $7,947 - $18,948	447 Added 9.88%	4,972 $123,000
Q1 2022 Jun 20, 2023	BUY	$29.67 - $60.28 $13,262 - $26,945	447 Added 9.88%	4,972 $192,000
Q1 2022 Mar 30, 2023	SELL	$29.67 - $60.28 $474,927 - $964,901	-16,007 Reduced 76.3%	4,972 $192,000
Q1 2022 May 12, 2022	SELL	$29.67 - $60.28 $474,927 - $964,901	-16,007 Reduced 76.3%	4,972 $193,000
Q4 2021 Jun 21, 2023	BUY	$47.84 - $64.34 $787,159 - $1.06 Million	16,454 Added 363.62%	20,979 $1.23 Million
Q4 2021 Mar 30, 2023	SELL	$47.84 - $64.34 $41,381 - $55,654	-865 Reduced 3.96%	20,979 $1.23 Million
Q4 2021 Feb 15, 2022	SELL	$47.84 - $64.34 $41,381 - $55,654	-865 Reduced 3.96%	20,979 $1.23 Million
Q3 2021 Jun 21, 2023	BUY	$59.27 - $95.73 $1.03 Million - $1.66 Million	17,319 Added 382.74%	21,844 $1.29 Million
Q3 2021 Mar 30, 2023	BUY	$59.27 - $95.73 $14,106 - $22,783	238 Added 1.1%	21,844 $1.29 Million
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $14,106 - $22,783	238 Added 1.1%	21,844 $1.3 Million
Q2 2021 Jun 21, 2023	BUY	$67.25 - $92.52 $1.15 Million - $1.58 Million	17,081 Added 377.48%	21,606 $1.88 Million
Q2 2021 Mar 30, 2023	BUY	$67.25 - $92.52 $91,661 - $126,104	1,363 Added 6.73%	21,606 $1.88 Million
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $1.45 Million - $2 Million	21,586 Added 107930.0%	21,606 $1.88 Million
Q1 2021 Jun 26, 2023	BUY	$72.16 - $117.4 $1.13 Million - $1.85 Million	15,718 Added 347.36%	20,243 $1.67 Billion
Q1 2021 Mar 30, 2023	BUY	$72.16 - $117.4 $21,503 - $34,985	298 Added 1.49%	20,243 $1.67 Million
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $1.44 Million - $2.34 Million	-19,925 Reduced 99.9%	20 $1.67 Million
Q4 2020 Jun 22, 2023	BUY	$38.09 - $100.95 $587,347 - $1.56 Million	15,420 Added 340.77%	19,945 $1.81 Million
Q4 2020 Mar 30, 2023	SELL	$38.09 - $100.95 $31,538 - $83,586	-828 Reduced 3.99%	19,945 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $31,538 - $83,586	-828 Reduced 3.99%	19,945 $1.81 Million
Q3 2020 Jun 26, 2023	BUY	$30.41 - $40.5 $494,101 - $658,044	16,248 Added 359.07%	20,773 $830,000
Q3 2020 Mar 30, 2023	BUY	$30.41 - $40.5 $50,389 - $67,108	1,657 Added 8.67%	20,773 $830,000
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $50,389 - $67,108	1,657 Added 8.67%	20,773 $830,000
Q2 2020 Jun 26, 2023	BUY	$20.21 - $35.23 $294,884 - $514,040	14,591 Added 322.45%	19,116 $655,000
Q2 2020 Mar 30, 2023	BUY	$20.21 - $35.23 $13,864 - $24,167	686 Added 3.72%	19,116 $655,000
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $13,864 - $24,167	686 Added 3.72%	19,116 $656,000
Q1 2020 Jul 12, 2023	BUY	$17.28 - $31.88 $240,278 - $443,291	13,905 Added 307.29%	18,430 $409,000
Q1 2020 Mar 30, 2023	SELL	$17.28 - $31.88 $20,217 - $37,299	-1,170 Reduced 5.97%	18,430 $409,000
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $20,217 - $37,299	-1,170 Reduced 5.97%	18,430 $409,000
Q4 2019 Jul 12, 2023	BUY	$13.39 - $20.73 $201,854 - $312,504	15,075 Added 333.15%	19,600 $383,000
Q3 2019 Jul 12, 2023	BUY	$15.47 - $22.5 $233,210 - $339,187	15,075 Added 333.15%	19,600 $304,000
Q3 2019 Mar 30, 2023	SELL	$15.47 - $22.5 $12,731 - $18,517	-823 Reduced 4.03%	19,600 $304,000
Q3 2019 Nov 14, 2019	SELL	$15.47 - $22.5 $12,731 - $18,517	-823 Reduced 4.03%	19,600 $304,000
Q2 2019 Jul 12, 2023	BUY	$15.61 - $20.44 $248,167 - $324,955	15,898 Added 351.34%	20,423 $414,000
Q1 2019 Jul 13, 2023	BUY	$13.15 - $18.71 $209,058 - $297,451	15,898 Added 351.34%	20,423 $358,000
Q1 2019 Mar 30, 2023	BUY	$13.15 - $18.71 $203,180 - $289,088	15,451 Added 310.76%	20,423 $358,000
Q1 2019 May 16, 2019	SELL	$13.15 - $18.71 $186,125 - $264,821	-14,154 Reduced 40.93%	20,423 $358,000
Q1 2019 May 15, 2019	BUY	$13.15 - $18.71 $186,125 - $264,821	14,154 Added 69.3%	34,577 $2.49 Million
Q4 2018 Jul 13, 2023	BUY	$11.48 - $16.98 $182,509 - $269,948	15,898 Added 351.34%	20,423 $262,000
Q4 2018 Feb 14, 2019	BUY	$11.48 - $16.98 $191,670 - $283,498	16,696 Added 447.97%	20,423 $262,000
Q3 2018 Jul 13, 2023	BUY	$8.75 - $16.29 $104,492 - $194,535	11,942 Added 263.91%	16,467 $268 Million
Q3 2018 Nov 14, 2018	SELL	$8.75 - $16.29 $111,475 - $207,534	-12,740 Reduced 77.37%	3,727 $61,000
Q2 2018 Aug 15, 2018	BUY	$9.16 - $13.48 $6,118 - $9,004	668 Added 4.23%	16,467 $0
Q1 2018 May 15, 2018	BUY	$6.3 - $13.77 $99,533 - $217,552	15,799 New	15,799 $0

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account